Ancora Advisors’s Zai Lab ZLAB Stock Holding History

Ancora Advisors’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15	Closed	-$265	–	2568
2025 Q4	$265	Hold	15	–	–	﹤0.01%	2351
2025 Q3	$508	Sell	15 -9	-38%	-$310	﹤0.01%	1832
2025 Q2	$839	Buy	+24	New	+$789	﹤0.01%	1773

Other funds holding ZLAB

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Ancora Advisors's ZLAB Position: Q1 2026 in Review

Ancora Advisors sold out of Zai Lab (ZLAB) in Q1 2026, closing a stake of 15 shares — an estimated $265 sold.

Ancora Advisors first reported a position in ZLAB in Q2 2025 and held it in 3 quarters. The position peaked at $839 in Q2 2025. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

Ancora Advisors reported no remaining Zai Lab position as of Q1 2026 after selling out during the quarter.
Ancora Advisors sold 15 Zai Lab shares in Q1 2026, an estimated $265.
Ancora Advisors first reported a position in Zai Lab in Q2 2025 and held it in 3 quarters.
Ancora Advisors's Zai Lab position peaked at $839 in Q2 2025.
99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.